• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Optimize EP Launches CaRM Cardiac Device Data Management Platform

    U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030

    FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR

    Cognito Therapeutics’ Lead Product Receives FDA Breakthrough Device Designation

    Moon Surgical Expands Leadership Team
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Medbio LLC

    Creganna Medical, part of TE Connectivity

    MW Life Sciences

    FUTEK Advanced Sensor Technology Inc.

    Concise Engineering
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Creganna Medical, part of TE Connectivity

    Spectrum Plastics Group

    FUTEK Advanced Sensor Technology Inc.

    Element

    MW Life Sciences
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Top30

    7. Siemens Healthineers

    ...

    Related CONTENT
    • Catching Its Breath: Observations from the 2019 Top Companies Reports
    • The 2019 Top 30 Global Medical Device Companies
    • 1. Medtronic
    • 4. Abbott
    • 7. Cardinal Health
    07.30.19
    AT A GLANCE
    Rank: #7 (Last year: #4)
    $15.58 Billion
    Prior Fiscal: $15.9 Billion
    Percentage Change: -2%
    No. of Employees: 50,000
    Global Headquarters: Erlangen, Germany

    KEY EXECUTIVES
    Michael Sen, Chairman
    Dr. Bernd Montag, CEO
    Dr. Jochen Schmitz, CFO
    Michael Reitermann, Member of the Managing Board and President—Diagnostics Segment

    For years, there has been speculation regarding a number of conglomerates that would see the company spin out its medical device business. Rumors have circulated around Johnson & Johnson, GE Healthcare, Alcon (which was finally launched by parent Novartis in April), among others. In 2018, Siemens took the first steps toward creating a new, independent entity comprised of its Healthineers unit.

    On March 16, 2018, shares of Siemens Healthineers (representing a 15 percent stake in the company) debuted on the Frankfurt stock exchange. The shares were issued at a price of 28 euros (which immediately rose 7 percent during trading that same day)—a “discounted price” cited by some market participants as a way for Siemens to promote interest. The asking price was down from the figure initial estimates had it at when the IPO announcement was made in November of the year prior. At that time, speculation put the company’s value at 40 billion euros. Ultimately, however, Healthineers’ equity was valued at 28 billion euros for the IPO debut—still the world’s largest in the healthcare sector to date, according to Siemens Chairman Michael Sen.

    “The public listing is the next logical step and the foundation for expanding our strong position as a leading global supplier of healthcare technology,” Sen, who also serves as chairman of the Siemens Healthineers supervisory board, said in a statement.

    The sale brought $4.2 billion euros to the coffers of the former parent firm Siemens, which still retained an 85 percent stake. The move, according to management, will enable the standalone healthcare entity to raise its own funds for takeovers and investments.

    Undoubtedly, the firm is still evaluating potential prospects for acquisition as it hasn’t made any big splashes in that area since the IPO debut. Prior to that, however, the Healthineers segment of Siemens did conduct some M&A activity. Most notably, at the close of 2017, the unit announced it would be integrating Fast Track Diagnostics (FTD) into the fold. The Luxembourg-based company was a global supplier of diagnostics tests that could distinguish between viral, bacterial, or other infections in one test. FTD’s tests are real-time polymerase chain reaction (PCR) kits, allowing for both singleplex and syndromic testing. The acquisition increases the menu of the Siemens Healthineers’ VERSANT kPCR Molecular System by over 80 assays and syndromic panels.

    “Combining FTD’s wide range of assays with the Siemens Healthineers portfolio means great things for all of our customers globally,” explained Bill Carman, CEO of Fast Track Diagnostics. “In merging our efforts, we’re enabling healthcare providers to meet their current challenges and deliver better outcomes for patients.”

    While FTD’s 80 employees and sites in Luxembourg, Malta, and India were integrated into the firm, Healthineers retained the company’s name as the brand for the products available worldwide.

    Just prior to the FTD announcement, Siemens Healthineers confirmed the closing of an earlier transaction, wrapped up at the end of October 2017. While the financial details were not disclosed, the move resulted in Epocal Inc. being fully incorporated into its new owner.

    Epocal’s product line of blood gas offerings were tied to Healthineers’ POC Ecosystem. The resulting solution enables customized testing offerings based on individual facility needs—whether handheld testing, benchtop solutions, or central lab applications—to help improve process efficiency.

    Healthineers is hoping the addition of these organizations will help bolster a product catalog that resulted in lower overall sales revenue in the firm’s 2018 fiscal year, which experienced a decrease in review by almost 250 million euros when compared to the prior period. That translated to 13.43 billion euros in the most recent annual report versus the previous 13.68 billion euros. On a comparable basis, however, the company noted an increase of 4 percent.

    Siemens Healthineers is comprised of three segments—Imaging, Diagnostics, and Advanced Therapies. At 8.15 billion euros in 2018 fiscal revenue, the Imaging business led the company’s sales, but it was still relatively flat compared to the prior fiscal. According to the company, the magnetic resonance unit demonstrated particularly strong growth, though.

    Contributing an amount less than half of the Imaging sales, Diagnostics finished the fiscal period at 3.96 billion euros, a 5 percent decrease versus 2017’s 4.16 billion euros. In its annual report, the company attributes this decrease to negative currency translation effects.

    Rounding out the financial story for the company’s business segments, Advanced Therapies posted 1.48 billion euros to the annual total. The segment experienced a 2 percent decrease over prior fiscal, which was just over 1.5 billion euros, but 4 percent comparable growth. The company points to the growing trend toward minimally invasive procedures, which employ many of the firm’s technologies, for the comparable rise.

    On the global stage, the company’s sales are grouped into three regions. Its primary market—the Americas—saw a 5 percent decrease overall, dropping from 2017’s 5.57 billion euros to 2018’s 5.29 billion euros.

    The United States, which is the area’s largest revenue contributor, declined 4 percent year-over-year to finish at 4.46 billion euros. Next, Europe, the Commonwealth of Independent States, the Middle East, and Africa added 4.41 billion euros, a 2 percent rise over 2017’s 4.34 billion euros. Conversely, while the total was led by Germany’s 856 million euros, that sales total actually represented a decrease of 3 percent. Third was the Asia/Australia region, posting 3.73 billion euros, a slight 1 percent decrease over the previous fiscal year. China, on the other hand, which accounted for the highest revenue in the area, saw sales increase 4 percent to 1.68 billion euros.

    In an effort to spur future growth opportunities, the 2018 fiscal period saw several notable product announcements that should help turn around the sluggish “first-year” financials experienced by the newly launched entity.

    The company brought its Atellica Solution immunoassay and clinical chemistry analyzers for in-vitro diagnostic testing to market. According to a company statement, early adopters reported their respective workflow and performance studies, each of which validate the solution’s ambitious commitments to transform operational efficiency and enhance clinical performance. Their results exceeded key performance indicators that affect workflow—including turnaround time, throughput, operator hands-on time with system maintenance, and quality control, as well as assay performance.

    The firm also launched a new ultrasound solution—the Acuson Sequoia—which addresses the challenges of imaging different sized patients without compromising clarity. Equipped with a Deep Abdominal Transducer, a high-powered architecture, and updates to elastography and contrast-enhanced ultrasound, the Acuson Sequoia produces penetration up to 40 cm.

    Further additions to the Siemens Healthineers line of imaging solutions included four new CT systems. The SOMATOM go.All and SOMATOM go.Top expanded the range of clinical applications for the firm’s patient-centric mobile workflow operated via tablet and remote. The 64-slice All can cover scan ranges of up to 100 mm in one second, while the 128-slice Top performs whole-body scans of up to 200 cm with a scan speed of up to 175 mm per second. The addition of these solutions enable users to now employ the SOMATOM go. platform for applications in emergency medicine, interventional radiology, and cardiology, which the company notes as a major growth area for healthcare providers.

    The other two introductions were the SOMATOM Edge Plus—a single-source system—and the SOMATOM Force—a new version of the dual-source field system. Both allow users to cover all CT applications, regardless of patient or clinical issue. The precision diagnostic solutions employ integrated FAST (Fully Assisting Scanner Technologies) applications, such as the FAST Integrated Workflow with the new FAST 3D Camera for automatic patient positioning.

    Also of note was the company’s announcement of its new tests for diagnosing heart attacks faster. The High-Sensitivity Troponin I assays (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in-vitro diagnostic analyzers offer the ability to detect lower levels of troponin at significantly improved precision at the 99th percentile, and detect smaller changes in a patient’s troponin level as repeat testing occurs.

    In addition to bringing new products to market, Siemens Healthineers found innovative ways to repackage the technologies it already offered by establishing strategic partnerships with medical device firms that provided complementary solutions. In one such arrangement, NuVasive teamed with Siemens Healthineers to form a Spine Precision Partnership. The goal of this initiative is to create solutions that improve operating room workflow efficiency and provide increased precision in the delivery of minimally disruptive spine surgery technologies. The first step involved the integration of NuVasive’s Pulse surgical automation platform with Siemens Healthineers’ Cios Spin mobile 3D imaging for intra-operative quality assurance.

    “We at Siemens Healthineers are excited to work with NuVasive to develop intra-operative 3D-imaging and navigation tools for our advanced imaging systems that empower spine surgeons and neurosurgeons to be more precise, faster, and cost efficient in the operating room. Increased workflow efficiency, better image quality, as well as predictable and reproducible results, will transform care delivery and set a new standard in spine surgery,” said Peter Seitz, head of Surgery at Healthineers.

    Another cooperative effort paired the company with Hillrom to provide comprehensive diabetes care for primary care facilities. The integrated offering incorporates Siemens Healthineers’ DCA Vantage Analyzer for HbA1c testing and the CLINITEK Status+ Urine Chemistry Analyzer for kidney checks, with Hillrom’s Welch Allyn RetinaVue Network and imaging technology for teleretinal exams. The patient-centered solution from Siemens Healthineers and Hillrom offers physicians more control over patient care by accomplishing proactive testing and treatment during a single visit.

    Other medical device manufacturing firms weren’t the only participants in partnerships with Siemens Healthineers, however, during the 2018 fiscal year. The company teamed directly with healthcare providers in South Carolina and Florida to enhance the quality and delivery of care.

    At the start of the 2018 calendar year, the organization announced it was embarking on a multi-phase collaboration with Florida Hospital, part of Adventist Health System. The agreement involved the two entities seeking to transform the delivery of healthcare through the development of outcomes-based projects. Specifically, Healthineers would provide its imaging technology innovation and industry expertise to be combined with the healthcare provider’s integrated delivery network along with its ongoing investment in improving the affordability, outcomes, and experience for healthcare customers. According to a company statement, Phase I of the collaboration involved the incorporation of Healthineers’ cardiac computed tomography angiography into the hospital’s clinical protocol with the goal to optimally assess and manage intermediate-risk patients in Celebration Health’s emergency department who present with acute chest pain.

    Of the effort, David Pacitti, president of Siemens Healthineers North America, said “We look forward to conducting projects that closely examine the continuum of care and the development of clinical pathways that test and advance the strengths of both parties.”

    To that end, in August, the firm announced another collaboration. In this case, the partnership was to capitalize on the coupling of The Medical University of South Carolina’s (MUSC) clinical care, research, and education expertise with Siemens Healthineers’ engineering innovations and workflow-improvement capabilities. Specifically, according to the company’s release, the focus for this venture would be on driving performance excellence at MUSC and generating significant clinical and value-driven innovations in focused target areas including pediatrics, cardiovascular care, radiology, and neurosciences. For example, MUSC and Siemens team members planned to drastically reduce the time it takes for severe stroke patients to receive treatment. Another example involved the incorporation of artificial intelligence—referred to as “digital twin technology”—to enable planning teams to quickly determine the impact of changes that would be costly, if not impossible, to test in the real world, and help them forecast how well possible workflow solutions or health innovations may actually work.
    Related Searches
    • quality control
    • president
    • siemens
    • diabetes
    Suggested For You
    Catching Its Breath: Observations from the 2019 Top Companies Reports Catching Its Breath: Observations from the 2019 Top Companies Reports
    The 2019 Top 30 Global Medical Device Companies The 2019 Top 30 Global Medical Device Companies
    1. Medtronic 1. Medtronic
    4. Abbott 4. Abbott
    7. Cardinal Health 7. Cardinal Health
    13. EssilorLuxottica 13. EssilorLuxottica
    15. B. Braun 15. B. Braun
    16. Alcon 16. Alcon
    19. Olympus 19. Olympus
    20. Terumo 20. Terumo
    26. Hoya 26. Hoya
    29. Hillrom 29. Hillrom
    30. Sonova 30. Sonova
    Siemens Allies with Universities to Enhance Care Delivery Siemens Allies with Universities to Enhance Care Delivery
    Hillrom Sells Surgical Consumables Business to Audax for $170M Hillrom Sells Surgical Consumables Business to Audax for $170M

    Related Top30

    • The 2020 Top 30 Global Medical Device Companies

      The 2020 Top 30 Global Medical Device Companies

      Leadership changes, divestments, and portfolio-building partnerships—through acquisition or collaboration—were common threads among medtech’s largest players.
      MPO Editors 07.21.20

    • The 2019 Top 30 Global Medical Device Companies

      The 2019 Top 30 Global Medical Device Companies

      ...
      Sean Fenske, Michael Barbella, & Sam Brusco, MPO Editorial Staff 07.30.19

    • 1. Medtronic

      1. Medtronic

      ...
      07.30.19


    • 2. Johnson & Johnson

      2. Johnson & Johnson

      ...
      07.30.19

    • 3. GE Healthcare

      3. GE Healthcare

      ...
      07.30.19

    • 4. Abbott

      4. Abbott

      ...
      07.30.19


    • 5. Philips

      5. Philips

      ...
      07.30.19

    • 6. BD

      6. BD

      ...
      07.30.19

    • 7. Cardinal Health

      7. Cardinal Health

      ...
      07.30.19


    • 9. Stryker

      9. Stryker

      ...
      07.30.19

    • 10. Baxter

      10. Baxter

      ...
      07.30.19

    • 11. Boston Scientific

      11. Boston Scientific

      ...
      07.30.19


    • 12. Danaher

      12. Danaher

      ...
      07.30.19

    • 13. EssilorLuxottica

      13. EssilorLuxottica

      ...
      07.30.19

    • 14. Zimmer Biomet

      14. Zimmer Biomet

      ...
      07.30.19


    Trending
    • Meeting Critical Ventilator Product Requirements Amid Pandemic
    • STERIS To Buy Cantel Medical For $4.6B
    • Cytotron Gains Breakthrough Status To Treat Breast, Liver, And Pancreatic Cancers
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Medtech Matters: Talking Robotic Surgery With Zimmer Biomet
    Breaking News
    • Optimize EP Launches CaRM Cardiac Device Data Management Platform
    • U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030
    • FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR
    • Cognito Therapeutics’ Lead Product Receives FDA Breakthrough Device Designation
    • Moon Surgical Expands Leadership Team
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Brown Fat Associated with Reductions in Chronic Disease Risk
    NIH Study Identifies Antibacterial Properties in Taurine
    NSF Begins New Certification Program
    Coatings World

    Latest Breaking News From Coatings World

    Zeppelin Acquires MTI Mischtechnik
    Ezio Braggio Joins ChemQuest Europe
    IFS Coatings Announce Carbon Offset Program
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Optimize EP Launches CaRM Cardiac Device Data Management Platform
    U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030
    FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR
    Contract Pharma

    Latest Breaking News From Contract Pharma

    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    Frontage Bolsters Clinical Services Capabilities
    Sanofi Unveils EUROAPI as Name of New European API Company
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Neenah to Host Packaging Webinar for Printers
    W.S. Badger is Named a ‘150 Top Impact Company’
    Mana Products, Meiyume and RPG Form The Vertical Beauty Alliance
    Happi

    Latest Breaking News From Happi

    Amyris Named a Top Social & Environmental Impact Company
    L'Oréal Bans Animal Hair in Brushes
    Ashland Launches Antaron ECo Gel
    Ink World

    Latest Breaking News From Ink World

    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Techkon USA, Konica Minolta Partner
    Alon Bar-Shany Appointed Chairman of Highcon Board
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Exhibitor registration opens for virtual.drupa
    FTA planning in-person Forum & INFOFLEX
    Fortis Solutions Group achieves SGP certification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Shemesh Adds U.S. Headquarters
    TZMO USA, Special Needs Group Form Partnership
    BAHP Announces 2021 Officers, Board of Directors
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Rapid Recovery Protocol Can Lead to Increased Range of Motion After TKA
    Boston Scientific Releases WaveWriter Alpha Spinal Cord Stimulators in U.S.
    New Chief Clinical Officer on Board at IncludeHealth
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Toppan Announces 2050 Environmental Vision
    SOI Industry Consortium Joins SEMI as Strategic Association Partner

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login